Value-based Health Care Impact on Cardiovascular and Metabolic Diseases

Abstract

Cardiometabolic diseases include conditions of metabolic changes starting with insulin resistance, dyslipidemia, hypertension, and obesity that affect the cardiovascular system. In Brazil, cardiovascular diseases were the leading cause of death in 2019, with coronary disease and stroke being on top, with a population prevalence of 6.1%. 1 It is estimated that more than 17 million Brazilians have diabetes, 46% of whom are unaware of the disease. Associated illnesses such as ischemic disease, stroke, and diabetes represent a high economic burden on health systems, justified by their high incidence, population aging, and increasing incorporation of more expensive technologies.